Drugs / TILs infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07498595 | Mar 2026 → Mar 2028 expected | non-small cell lung carcinoma | Tianjin Medical University General Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TILs infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07498595 ↗ |
| Modality | Cell therapy | “Surgically collect fresh tumor tissue or malignant pleural effusion to isolate immune cells, and prepare TILs Infusion.” NCT07498595 ↗ |
| Route | Intravenous | “Administration route: Intravenous Infusion” NCT07498595 ↗ |